The aftermath of the Merck's HIV vaccine trial
<p>Abstract</p> <p>The recently released results of the Merck's Phase IIb "test-of concept" vaccine trials have shown no protection from HIV-1 infection in the vaccinated group compared with a control group vaccinated with placebo. The study was designed to test the...
Egile Nagusiak: | , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
BMC
2008-07-01
|
Saila: | Retrovirology |
Sarrera elektronikoa: | http://www.retrovirology.com/content/5/1/56 |